• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Former Corindus CEO Toland joins medtech investment firm

Former Corindus CEO Toland joins medtech investment firm

September 15, 2020 By Sean Whooley

BioStar Capital announced today that former Corindus Vascular Robotics CEO Mark Toland has joined the firm as a partner and EIR.

As a partner and entrepreneur in residence (EIR), Toland is slated to help in the discovery, development and nurturing of new startups with high-growth potential. He will also have the flexibility to function in a number of roles with these companies, including consultant, board member or other executive leadership positions, according to a news release.

Toland’s tenure at Corindus, a recent Siemens Healthcare portfolio purchase, included leading the company to develop and launch its CorPath GRX, which Corindus currently touts as the only FDA-cleared and CE-Marked robotic system for endovascular coronary and peripheral vascular interventions.

Before Corindus, Toland served as senior VP at Boston Scientific, working on the company’s commercial impact across all business segments, having also held roles with the company’s sales operations for interventional cardiology, cardiac rhythm management, peripheral interventions and electrophysiology.

“The time is now for advanced technology to fundamentally reshape healthcare,” Toland said in the release. “In my time at Corindus, I saw firsthand how the world, partially in response to COVID, has embraced technology, not only from within the clinical community but at a societal level.

“My colleagues at BioStar are uniquely focused on finding and developing innovative companies ready to leverage AI, Deep Learning, Robotics and other transformative technologies to address a wide range of healthcare inefficiencies and inequities.”

Toland is set to join a BioStar team that has invested in more than 30 medical device startups, with nearly half of them acquired by major medical device manufacturers, including Boston Scientific, Medtronic and Covidien.

“Having been an early investor in Corindus, the BioStar team and I have had the privilege of working with Mark for several years and experiencing firsthand his innate leadership ability, and we’re thrilled to have him aboard,” BioStar founder & senior managing director Dr. Louis Cannon said. “Mark’s knowledge, connections, tenacity, and unique ability to innately deconstruct complex situations into clear, actionable paths will greatly benefit our investors and limited partners, our startups, and most importantly, positively impact the lives of patients.”

Filed Under: Business/Financial News, Cardiovascular, Funding Roundup, Surgical, Surgical Robotics, Vascular Tagged With: BioStar Capital, Corindus Vascular Robotics, Personnel Moves

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy